Items where authors include "Mallappa, A."

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 6.

Article

Tschaidse, L., Reisch, N. orcid.org/0000-0002-7469-6069, Arlt, W. orcid.org/0000-0001-5106-9719 et al. (15 more authors) (2023) Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia. European Journal of Endocrinology, 188 (1). lvac006. pp. 109-117. ISSN 0804-4643

Merke, D.P., Mallappa, A., Arlt, W. et al. (14 more authors) (2021) Modified-release hydrocortisone in congenital adrenal hyperplasia. The Journal of Clinical Endocrinology & Metabolism, 106 (5). e2063-e2077. ISSN 0021-972X

Merke, D.P., Mallappa, A., Arlt, W. et al. (14 more authors) (2020) OR25-02 A phase 3 study of a modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia. Journal of the Endocrine Society, 4 (Supplement_1).

Karunasena, N., Han, T.S., Mallappa, A. et al. (4 more authors) (2017) Androgens correlate with increased erythropoiesis in women with congenital adrenal hyperplasia. Clinical Endocrinology, 86 (1). pp. 19-25. ISSN 0300-0664

Jones, C.M., Mallappa, A., Reisch, N. et al. (10 more authors) (2016) Modified release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism. jc20162855. ISSN 0021-972X

Debono, M., Mallappa, A., Gounden, V. et al. (7 more authors) (2015) Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers. European Journal of Endocrinology, 173 (6). pp. 727-737. ISSN 0804-4643

This list was generated on Sun Mar 24 06:47:46 2024 GMT.